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Abstract – Alzheimer’s disease (AD), the most prevalent dementia, is characterized not only by cognitive but also behavior-
al changes that pose the heaviest burden to caregivers. Differences in the clinical picture depending on the time of disease 
onset have been observed. We correlated cognitive and behavioral deficits in patients with presenile- and senile-onset AD 
to explore the differences. We tested 60 AD patients, 19 male and 41 female, mean age 65.2 years with the Dementia Behav-
ior Disturbance Scale (DBD) and a standard neuropsychological battery. The patients were divided according to their DBD 
score into two groups: group I – score 0-2 (n=24; 40%), group II – score 3≥ (n=36; 60%), comparable in disease duration 
and neurological findings. The cognitive scores were significantly higher in the group with less behavioral changes than in 
the group with more behavioral changes: Mini Mental State Examination score (p=0.0015), serial subtraction (p=0.0009), 
block design (p=0.0049), copy of complex figure (p=0.0125), complex visual organization (p=0.0099), divided attention, 
visual memory and speech comprehension. A significantly higher frequency of behavioral disturbances was registered in 
patients with senile onset than in the presenile-onset group (p<0.005). There were no sex differences. Our data show a 
correlation between cognitive decline and behavioral changes in late onset AD patients, indicating that more behavioral 
disturbances were associated with a more severe degree of cognitive decline, especially in non-verbal functions and atten-
tion deficits, compared to early onset patients.
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INTRODUCTION
AD is a neurodegenerative disease that causes se-
lective neuronal loss in brain regions involved in 
memory, language, personality and cognition in 
general (Feng and Wang, 2012). AD is the most 
frequent type of dementia and can begin before 
the age of 65 (presenile or early onset) and after 65 
years (senile or late onset) by usual arbitrary cut off 
(Rabinovici et al., 2010). The earliest symptom of 
AD is typically a progressive memory loss of insidi-
ous onset, while other cognitive areas, usually lan-
guage, executive function and visuospatial skills, 
are also present during the course of the disease 
(von Gunten et al., 2006). The main pathological 
features in the cerebral cortex are neurofibrillary 
tangles (NFT), senile plaques (SP) and neuronal 
and synaptic loss. As these processes spread from 
medial temporal cortex along the neocortex, the 
spectrum of cognitive and behavioral symptoms 
broadens. The clinicohistopathological relation-
ship has been well established and depends mostly 
on NFT density in specific regions (von Gunten et 
al., 2006).
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Heterogeneity is present in AD with regard to ge-
netic characteristics, neuropathological findings and 
neuropsychological profile (Kim et al., 2005). How-
ever, the most disturbing feature for family members 
and caregivers are behavioral changes that lead to 
the early institutionalization of these patients (Pel-
letier and Landreville, 2007). Behavioral signs pose 
the heaviest economical burden for both family and 
society. The sense of discomfort is significantly as-
sociated with overall agitation, non-aggressive physi-
cal behavior and verbally agitated behavior (Pelletier 
and Landreville, 2007). 
The investigation of the relationship between 
cognitive and behavioral changes in AD in relation 
to the time of disease onset is of interest for both 
pathophysiological considerations and the everyday 
management of AD patients. However, this topic has 
not been addressed so far in detail. The aim of this 
study was to disclose if behavioral disturbances are 
more frequent in patients with presenile or senile on-
set of AD and their relationship with various cogni-
tive measures.
PATIENTS AND METHODS
We conducted a retrospective study with 60 patients 
from an outpatient behavioral neurology service in 
a university hospital with AD by NINCDS-ADRDA 
criteria (McKhann et al., 1984), 19 male and 41 fe-
male, mean age 65.2 years, mean education level 13.5 
years. 
Data were collected from the patients’ histories. 
Behavioral changes were assessed with the Dementia 
Behavior Disturbance Scale (DBD) (Baumgarten et 
al., 1990). Behavioral symptoms were graded from 0 
to 4 (from absence of symptoms = 0, to most disturb-
ing = 4). Patients were divided arbitrarily into two 
groups: Group 1 with scores 0-2 that consisted of 24 
(40%) patients and Group 2 with scores of 3 and 4 
that consisted of 36 (60%) patients. 
The groups were compatible in terms of disease 
duration, neurological status and structural neu-
roimaging data (p>0.05). Disease was staged accord-
ing to the Clinical Dementia rating (CDR; Hughes et 
al., 1982). 
The comprehensive neuropsychological bat-
tery included the Mini Mental State Examination 
(MMSE) (Folstein et al., 1975), the Block design 
from Serbian version of WAIS (Veksler’s “Individual 
Intelligence Test” (“Individualni Test Inteligencije”) 
= VITI), the Rey Complex Figure (RCF) (Rey, 1964) 
copy and delayed recall, the Hooper Visual Organi-
zation Test (HVOT) (Hooper, 1958), the Trail Mak-
ing Test (TMT A & B) (Reitan and Wolfson, 1993), 
the Rey Auditive Verbal Learning Test (RAVLT) 
(Rey, 1964), speech comprehension from the Boston 
Diagnostic Aphasia Battery (BDAE) and the Boston 
Naming Test (BNT) (Kaplan et al., 1978), categori-
cal and phonemic fluency tests for divergent think-
ing and the Luria 3 Step Test for limb-kinetic praxia 
(Lezak et al., 2004). Data were analyzed with the T-
test, X2-test and Fisher’s test.
RESULTS
We found no gender difference in regard to mean age, 
mean age at disease onset, mean of disease duration, 
mean CDR score and MMSE score (T-Test: p>0.05). 
Behavioral changes did not show significant sex dif-
ference (X2-test: p>0.05). There was no significant 
difference between senile and presenile AD onset ac-
cording to mean MMSE score (T-test: p>0.05), but 
patients with senile onset had significantly higher 
CDR scores (T-test: p<0.05). Fisher’s test showed 
significantly higher frequency of behavioral distur-
bances in patients with senile beginning than in the 
presenile group (p=0 p<0.05). 
The most frequent disturbances were, according 
to DBD, apathy (loss of interest in everyday activities) 
27, purposeless laughter and crying 16, losing things 
11, agitation 9, accusations 7, loses of way outside of 
home 6, repeating the same questions 5, waking up 
during the night for no reason 5, repetition of the 
same activity 4, excessive daytime sleeping 3, pacing 
3, night wandering at home 3, resisting to eat 3, wan-
dering outside the home 2, physical aggressiveness 2, 
and cursing, refusing help, stool incontinence.
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We identified a negative correlation between 
MMSE score and behavioral changes in the senile 
type of AD (T-Test: p<0.05) while there was no cor-
relation in the presenile group (p>0.05). Dementia 
duration did not influence behavior in either group 
(T-Test: presenile: p>0.05; senile: p>0.05).
Neuropsychological test scores were significantly 
higher in the group without significant behavioral 
disturbances (group I) than in the group with sig-
nificant behavioral disturbances (group II) for the 
following assessments: MMSE (p=0.0015), serial 
subtraction “100-7” from MMSE (p=0.0009), visual 
attention span (p=0.08 – trend), TMT A (p=0.019), 
TMT B (p=0.03), block design (VITI) (p=0.0049), pic-
ture completion (VITI) (p=0.050), RCF (p=0.0125), 
HVOT (p=0.0099), RCF recall: 3 minutes (p=0.019) 
and 40 minutes (p=0.035), verbal divergent think-
ing: phonemic fluency (p=0.012) and categorical flu-
ency (p=0.031), speech comprehension: commands 
(p=0.0082) and CIM (p=0.001) as well as dynamic 
praxia of the left hand (p=0.003) and the right hand 
(p=0.001). No statistically significant difference was 
detected for scores on BNT and RAVLT test, or for 
verbal attention span.
DISCUSSION
Our data showed more advanced cognitive decline 
and more behavioral disturbances in senile-onset 
AD patients than in the presenile-onset group. In 
addition, late onset patients had higher CDR scores 
and their behavioral and cognitive aspects were sig-
nificantly associated. There were no significant dif-
ferences according to sex and disease duration. The 
measure of general cognitive deterioration, MMSE 
score, differs between patients with senile and prese-
nile onset. Significantly lower scores in the late onset 
AD patients were detected on the testing of sustained 
and divided attention, constructive and limb kinetic 
praxia, working and visual memory, divergent think-
ing, visuospatial gnosia, complex ideational material 
comprehension and visual attention span. 
Verbal measures of confrontational naming and 
verbal attention span were not significantly different 
and these functions are known as most resistant to 
deterioration. In addition, verbal learning did not 
show differences between presenile and senile-onset 
patients, probably because these are the core neu-
ropsychological deficits, usually present at the very 
beginning of the disease. 
The most frequent behavioral disturbances in 
our patients were apathy (loss of interest in every-
day activities), purposeless laughter and crying, los-
ing things, agitation and accusations. Patients with 
behavioral disturbances showed more pronounced 
neuropsychological dysfunctions of prefrontal func-
tions such as divergent verbal thinking (phonemic 
fluency), working memory and limb-kinetic praxia, 
or dynamic apraxia in Luria’s terminology. Verbal 
functions are more resistant to disease process in-
fluence than non-verbal functions. Our results are 
partly similar to the findings of Hirono et al. (1998) 
in which older age, female sex, longer duration of 
illness and more severe cognitive impairment were 
independently associated with the occurrence of 
psychosis. It has also been shown that aggressive 
behavior and depressive symptoms are associated 
with progressive cognitive decline in elderly subjects 
(Margari et al., 2012).
Investigation with voxel based magnetic reso-
nance imaging (MRI) morphometry revealed a cor-
relation between behavioral disturbance and grey 
matter brain atrophy of certain areas (Bruen et al., 
2008). Delusions were associated with decreased 
grey matter density in the left frontal lobe, in the 
right frontoparietal cortex and in the left claustrum; 
apathy was associated with grey matter density loss 
in the anterior cingulate and frontal cortex bilater-
ally, the head of the left caudate nucleus and in bi-
lateral putamen; agitation was associated with de-
creased grey matter values in the left insula, and in 
the anterior cingulate cortex bilaterally. These AD 
symptoms seem to be associated with neurodegen-
eration of the neural networks supporting functions 
that are of importance for both behavioral planning 
and control and cognitive functions. This is consist-
ent with our clinical findings. A prospective study of 
AD with post mortem verification reported similar 
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clinical patterns dominated by dysmnesia, dysphasia, 
dyspraxia and spatial disorientation in both groups, 
while confabulation, restlessness, confusional epi-
sodes, fluctuating course and hallucinosis agitation 
were somewhat more prevalent in the late onset AD 
(Gustafson, 1990).
There are various possibilities that can influence 
the differences that we found between patients with 
early and late onset. It could be due to more frequent 
comorbidities, inadequate polypharmacy and the 
involvement of cerebrovascular factors in older pa-
tients, the existence of different AD subtypes or the 
effects of propagation of uniform pathological proc-
ess specific to AD. These characteristics can reflect 
the more extensive cortical pathological changes in 
older patients involving also the frontal besides the 
“classical” temporoparietal areas.
Behavioral disturbances were more frequent in 
patients with senile AD onset. Cognitive status was 
independent from behavioral changes in the prese-
nile patients but significantly influenced behavior in 
the senile patients in our groups. Psychotic symp-
toms have been associated with accelerated cognitive 
deterioration in some studies (Drevets and Rubin, 
1989) but others found no significant influence of 
age at onset, duration of illness or family history of 
dementia (Ortof and Crystal, 1989). Memory im-
pairment is present in AD regardless of age of on-
set, while confabulations, delusions and sleep dis-
turbances are more frequent in late-onset patients 
(Lauter, 1970). Our findings are in accord with these 
studies, in addition, we examined cognitive decline 
with a comprehensive battery of neuropsychological 
tests. Divided attention decline can have a negative 
influence on the comprehension of social situations 
with multiple environmental cues as well as impaired 
comprehension of complex ideational material. 
Cortical atrophy differences were found be-
tween patients with presenile and senile AD onset 
using MRI with voxel-based morphometry (Ishii 
et al., 2005). Typical parietotemporal and posterior 
cingulate gray matter loss was found in presenile-
onset AD but not in senile-onset AD. These changes 
point to atypical loci of brain atrophy in late-onset 
AD mediating behavior in the prefrontal cortex (von 
Gunten et al., 2006). Clinically, some studies showed 
that patients with presenile-onset AD have more 
non-memory disturbance initially with a more rapid 
progression of cognitive deficits compared with late 
onset patients (Ishii et al., 2005). In our patients, the 
main difference between the two groups with differ-
ent time of onset was in predominantly behavioral 
disturbances in late onset group. These differences 
may reflect the two distinct pathological processes 
with predominant involvement in prefrontal/tem-
poral neocortical structures that mediate behav-
ior. For instance, it is well known that up to 60% of 
the spindle neurons of the anterior cingulate cortex 
(ACC) are lost in AD (Nimchinsky et al., 1995) and 
the dysfunction of ACC positively correlates with the 
behavioral and psychological symptoms of dementia 
(BPSD) (Shinno et al., 2007). 
The positive correlation between cognitive and 
behavioral symptoms in late onset AD can be caused 
by the more frequent existence of comorbidities in 
the older population with more pronounced vascu-
lar factors (Yarchoan et al., 2012). The dysfunction 
of subcortical structures, as in white matter ischemic 
changes in older age, are neuropsychologically mani-
fested with a prefrontal type of disturbances and this 
might be an independent factor but could possibly be 
intermingled with other contributing factors. 
Disease duration was comparable in our patients 
both with and without behavioral changes, although 
it is known that behavioral disturbances are more 
characteristic of the later course of AD, mostly de-
pression, anxiety, psychosis and other BPSD symp-
toms (Kennedy et al., 2001). These studies do not 
account for the presenile/senile-onset dichotomy so 
that they might miss the difference in the course of 
the disease.
In accordance with the gradual spreading of cor-
tical (and subcortical) AD pathology from typical 
early temporoparietal areas, it had been showed in 
various studies that frontal symptoms are related to 
the severity of the disease (Edhag et al., 2008). The 
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data that we present reveal that the severity of both 
cognitive and behavioral symptoms increases in late 
onset patients and are interrelated. These findings 
suggest a more rapid progression and more diffuse 
pathological process in AD patients with behavioral 
disturbances. These patients had typically senile on-
set. A higher DBD score is an indicator of a more 
rapid decline and poorer prognosis in AD patients. 
Micronutrient deficiencies due to the progres-
sive decline of gastrointestinal functions and other 
causes have to be taken into account. Some degree of 
vitamin B12 deficiency is fairly regularly observed in 
the senile population, and a vitamin D3 deficiency is 
almost ubiquitous, to name just a few. Levels of vita-
min B12 in serum are progressively reduced with ag-
ing so that the clinical deficit is present in about 20% 
of people over the age of 60 (Nilsson-Ehle, 1998) 
and in around 40% of hospitalized geriatric patients 
(Shahar et al., 2001). Among all residents of care 
facilities for the elderly, normal vitamin B12 levels 
(>250 pmol/L) are present in only 50% (Mirkazemi 
et al., 2012). A deficiency of vitamin B12 can cause 
dementia, personality changes, delirium, psychosis, 
depression, hallucinosis, polyneuropathy, optic neu-
ropathy and myelopathy (Bernard et al., 1998). Vi-
tamin D deficiency (<50 nmol/L) is associated with 
increased odds in cognitive impairment in older per-
sons (Llewellyn et al., 2011). 
Another possible explanation is the greater 
cognitive reserve in younger patients that need 
more AD pathology to develop before compara-
ble changes observed by functional neuroimaging 
are expressed in late onset cases (Kim et al., 2005). 
It has been reported that early onset AD patients 
have more prominent focal neuropsychological 
symptoms such as aphasia, apraxia and agnosia 
than those with late onset (ibid). Brain functional 
imaging in AD yields controversial results, from 
no differences to a predominance of focal dysfunc-
tion in early to more diffuse findings in late onset 
(ibid). Memory impairment remains uniformly the 
most prominent neuropsychological deficit in AD 
(Petersen et al., 1994). Longitudinal studies demon-
strate that the rate of cognitive decline in AD is quite 
consistent from study to study and across different 
populations and is quite slow at the start of the ill-
ness, faster during the middle stage, and once again 
slow in the terminal phase of the illness (Mohs and 
Haroutunian, 2002). Interestingly, BPSD are epi-
sodic events that wax and wane over the course of 
AD, without progression (ibid). In our group, BPSD 
were more prominent in senile-onset patients with 
more pronounced cognitive deficits. This might 
be caused by the reduced capacity of comprehen-
sion of circumstances and relations in persons with 
more pronounced cognitive deficits leading to delu-
sional explanations of reality. Genetic factors have 
also to be appreciated as there are more inherited 
mutations among early onset dementia (Edhag et 
al., 2008) but specific gene polymorphisms can also 
be of interest. 
Some studies contradict our results. In the study 
of Rabinovici et al. (2010) patients with early age 
of AD onset showed a more rapid progression and 
more generalized cognitive deficits compared to late 
onset patients. These discrepancies may be due to 
the different populations targeted and the additional 
inclusion of behavioral measures in our study. In 
our group, there were no young onset patients, thus 
our cases being more representative of a continuum 
of the disease than distinguishing between the two 
subtypes. A comparable burden of fibrillar amyloid-
beta is associated with greater posterior cortical 
hypometabolism in early onset Alzheimer’s disease 
according to functional neuroimaging and amyloid-
beta imaging, possibly indicating that both early 
amyloid-beta accumulation and increased vulner-
ability to amyloid-beta pathology play critical roles 
in early onset AD (Rabinovici et al., 2010). We did 
not correlate neuroimaging data between cognitive 
and behavioral disturbances and specific functional 
brain areas. Possible aims of investigations would be 
to examine broader correlations of presenile- and 
senile-onset AD patients with cognition and behav-
ioral manifestations, also with micronutrient status, 
medical comorbidities and cerebrovascular factors. 
Not to be neglected is inadequate polypharmacy that 
is more often present in older patients (Edhag et al., 
2008). 
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Previous studies did not address the correlation 
of behavioral and cognitive clinical aspects and age 
of onset of AD with the comprehensive neuropsy-
chological battery that is available in clinical prac-
tice. Our findings reveal the necessity of a high level 
of alertness for behavioral disturbances in older pa-
tients with more pronounced cognitive decline and 
preventive measures in cases of medical comorbidi-
ties, infections, sleep disturbances, vascular risk fac-
tors and other relevant areas. In addition, of utmost 
importance are preventive measures in the early 
phases of AD.
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